Abstract
Background: Machine learning (ML), one aspect of artificial intelligence (AI), involves computer algorithms that train themselves. They have been widely applied in the healthcare domain. However, many trained ML algorithms operate as “black boxes”, producing a prediction from input data without a clear explanation of their workings. Non-transparent predictions are of limited utility in many clinical domains, where decisions must be justifiable. Methods: Here, we apply class-contrastive counterfactual reasoning to ML to demonstrate how specific changes in inputs lead to different predictions of mortality in people with severe mental illness (SMI), a major public health challenge. We produce predictions accompanied by visual and textual explanations as to how the prediction would have differed given specific changes to the input. We apply it to routinely collected data from a mental health secondary care provider in patients with schizophrenia. Using a data structuring framework informed by clinical knowledge, we captured information on physical health, mental health, and social predisposing factors. We then trained an ML algorithm to predict the risk of death. Results: The ML algorithm predicted mortality with an area under receiver operating characteristic curve (AUROC) of 0.8 (compared to an AUROC of 0.67 from a logistic regression model), and produced class-contrastive explanations for its predictions. Conclusions: In patients with schizophrenia, our work suggests that use of medications like second generation antipsychotics and antidepressants was associated with lower risk of death. Abuse of alcohol/drugs and a diagnosis of delirium were associated with higher risk of death. Our ML models highlight the role of co-morbidities in determining mortality in patients with SMI and the need to manage them. We hope that some of these bio-social factors can be targeted therapeutically by either patient-level or service-level interventions. This approach combines clinical knowledge, health data, and statistical learning, to make predictions interpretable to clinicians using class-contrastive reasoning. This is a step towards interpretable AI in the management of patients with SMI and potentially other diseases. Funding: UK Medical Research Council. Declaration of Interest: RNC consults for Campden Instruments Ltd and receives royalties from Cambridge University Press, Cambridge Enterprise, and Routledge. SB, PL and PJ declare they have no conflicts of interest to disclose. Ethical Approval: The CPFT Research Database operates under UK NHS Research Ethics approvals (REC references 12/EE/0407, 17/EE/0442; IRAS project ID 237953).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have